Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
Conditions: Malignant Pleural Effusion; Malignant Pleural Mesothelioma; Mesothelioma; Solid Tumor Intervention: Drug: RSO-021 Sponsor: RS Oncology LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials